{"summary": "heightened neuroplasticity allows the brain to reorganize and adapt to its environment. inflammation would putatively disrupt neuroplasticity. this work suggests inflammation during the childhood period could have unrecognized negative consequences. to model plasticity, we leveraged the paradigmatic ocular dominance model of in vivo developmental plasticity (Wiesel and Hubel, 1963) and generated transcriptional signatures from primary visual cortex (V1) to produce a diverse list of diseases ranked by their likelihood to dysregulate developmental plasticity. three to five animals per cage were group housed under a standard 12 h light/dark cycle. constant temperature (23\u00b0C) and ad libitum access to food and water. the institutional animal care and use committee approved all procedures involving animals. juvenile versus adult transcriptomes by first quantile normalizing probe-level data with limma. then computing rank-based differential expression with RankProd to yield 193 unique mouse Entrez IDs. we generated a Lynx1/ signature in an analogous manner to juvenile, to yield a 176 gene juvenile plasticity signature of 98 genes. a pathology score is the sum of the absolute value of the normalized disease signature gene expression that is shared with a hallmark gene set. a pathology score is the sum of the absolute value of the normalized disease signature gene expression that is shared with a hallmark gene set. negative values are pathological processes associated with diseases predicted to disrupt plasticity signatures. to calculate enrichments of top DLA gene sets, we chose a conservative cutoff of pcorrected 5 105. to calculate enrichments of top DLA gene sets, we chose a conservative cutoff of pcorrected 5 105. total RNA was extracted from V1 using the RNeasy Lipid Tissue Mini Kit (Qiagen) and stored at 80\u00b0C. RNA yields ranged from 4.5 to 10 g/sample and RNA integrity numbers ranged from 8.7 to 10 (mean, 9.8; SD, 0.32) total RNA was converted to cDNA using a High-Capacity cDNA Reverse Transcription Kit (Life Technologies) in vivo electrophysiology, the contralateral eye of experiment-naive P26 mice was sutured. the animal was immediately injected intraperitoneally with LPS. three days later, single-unit electrophysiological recordings were taken in binocular zone of V1 in response to visual stimuli presented to each eye separately. reversal of retinotopy seen as the electrode was moved into the secondary visual cortex. mice that experienced opening of the sutured eye or had poor recordings were excluded from further study. contralateral bias index (CBI) is a monocular weighted, animal-level summary statistic. a CBI value of 0.4 is ipsilateral dominant. for statistical comparison of ocular dominance, ODSs of single neurons were plotted as a proportion histogram and compared via a nonparametric 2 test. no specific p values reported, rather a group of genes under a specified p value threshold h Approximately normal Welch t test NA. no specific p values reported, rather a group of genes under a specified p value threshold h. plasticity signature generation Transcriptomes were profiled with microarray to generate plasticity signatures. a total of 4.5 g of cRNA was hybridized to Illumina WG-6 2.0 microarrays. a molecular matching score is the sum of the absolute value of the rank-difference gene expression measure of disease signatures. high scores indicate significant overlap between disease and plasticity signatures, whereas low scores indicate little or no overlap. the p value was chosen because the direction of effect for gene sets is not necessarily known. we calculated a linear regression between the pathology scores and disease\u2013plasticity scores (the 1 coefficient) by computing 20,000 permutations of pathology scores using gene sets the same length as the input gene set. values are pathological processes associated with diseases that are predicted to not disrupt plasticity signatures. to calculate enrichments of top DLA gene sets, we chose a conservative cutoff of pcorrected 5 105 and then calculated the over-representation of inflammation gene sets among positive DLA associations. quantitative PCR core facility using TaqMan probes (catalog numbers: NogoR:00445861, Lynx1: 01204957_g1, S100a8: 00496696_g1, Lrg1: 01278767_m1, Lrg1: 01324470_m1, PirB: 01700366_m1, Cldn5: 00727012_s1, Egr2: 00456650_m1, Npas three days later, single-unit electrophysiological recordings were taken in binocular zone of V1 in response to visual stimuli presented to each eye separately. visually evoked single-unit responses were recorded with 16-channel silicone probes (NeuroNexus) the signal was amplified and thresholded (OmniPlex, Plexon) ODI is linearly transformed by assigning [1.0, 0.5) = 1, [0.5, 0.3) = 2, [0.3, 0.1) = 3, [0.1, +0.1] = 4, (+0.1, +0.3] = 5, (+0.3, +0.5] = 6, (+0.5, +1.0] = 7. contralateral bias index (CBI) is a monocular weighted, animal-level summary statistic. a and b are the successes and m and n are the totals (totals determined by dividing the successes by the published incidence rates) the influenza 95% confidence interval (CI) for the incidence rate ratio was estimated using the Katz log approach. no specific p values reported, rather a group of genes above a specified p value threshold (e.g., not significant) l Approximately normal welch t test, one-sided (due to specific prior hypothesis as to direction of effect; results still significant using a two-sided test. inflammatory bowel disease, metabolic diseases. a broad range of disease states may impact molecular pathways involved in plasticity. a, b, 176 genes (represented by green bars) were matched to 436 disease signatures. N_2597827 Arc 11838 23237 Activity-regulated cytoskeletal-associated protein 15.7472 2.3415 0 0 ILMN_1230397 A630064P09Rik NA NA 15.7373 2.331 0 0 ILMN_2622983 Dusp1 19252 1843 Dual-specificity phosphatase 1 14.4292 2.3046 0 0 ILMN_3160970 Gpr17 574402 2840 97 1.9656 0 0 ILMN_1221178 Pdlim2 213019 64236 PDZ and LIM domain 2 38.5983 1.9267 5.00E-04 0 ILMN_2463181 Tnc 21923 3371 Tenascin C 37.2206 1.9239 5.00E-04 0 ILMN_2810882 Ppic 19038 5480 Peptidylprolyl isomerase C 41.0256 1.92 1223244 Hbb-b1 NA NA NA 71.2786 1.7908 0.0012 0 ILMN_2906855 Ky 16716 339855 Kyphoscoliosis peptidase 63.327 1.7828 7.00E-04 0 ILMN_2880906 Pdlim2 213019 64236 PDZ and LIM domain 2 79.6764 1.7799 0.0024 0 ILMN_1256343 H19 149 0 ILMN_1237021 Mag 17136 4099 Myelin-associated glycoprotein 107.5658 1.7077 0.0049 0 ILMN_2675874 Alas2 11656 212 Aminolevulinic acid synthase 2, erythroid 105.2858 1.6961 0.0049 0 ILMN_3161282 Dpysl5 65254 56896 Dihydropyrimidinase-like 5 2 13143 23604 Death-associated protein kinase 2 115.4908 1.6484 0.0078 0 ILMN_2777359 Serpinh1 12406 871 Serine (or cysteine) peptidase inhibitor, member 1 133.2106 1.6468 0.009 0 ILMN_2757125 Prc1 233406 9055 Protein regulator of cytokinesis 1 168.1391 1.645 0.0138 1.00E-04 Ky 16716 339855 Kyphoscoliosis peptidase 149.169 1.6067 0.0109 0 ILMN_2545963 Hbb-b1 NA NA NA 147.5637 1.6053 0.0108 0 ILMN_2769490 5430435G22Rik 226421 338382 RIKEN cDNA 5430435G22 gene 216.6505 1.6037 0.0234 1.00E-04 ILM 1258028 Gal3st1 53897 9514 Galactose-3-O-sulfotransferase 1 168.0194 1.5754 0.0139 1.00E-04 ILMN_2621544 2700060E02Rik 18074 22795 Nidogen 2 179.1935 1.5706 0.0159 1.00E-04 ILMN_2711163 Ctsk 13038 1513 Cathepsin K 203.95 33 1.545 0.0231 1.00E-04 ILMN_1239117 Hbb-b1 NA NA 221.9056 1.5432 0.0251 1.00E-04 ILMN_2638473 1190003M12Rik 68888 NA Gastrokine 3 202.5197 1.5425 0.0208 1.00E-04 ILMN_2753342 Hapln1 12950 1404 Hyaluronan and proteoglycan link protein 1 210.5965 1.5 k4 114255 55715 Docking protein 4 254.0057 1.5079 0.0341 2.00E-04 ILMN_2625854 2310016C16Rik 69590 493869 Glutathione peroxidase 8 (putative) 256.2349 1.5077 0.0342 2.00E-04 ILMN_1229726 Fibcd1 98970 84929 Fibrinogen C domain containing 1 304.0763 1.5074 ILMN_1257097 Cnp 12799 1267 2',3'-cyclic nucleotide 3' phosphodiesterase 288.7593 1.4897 0.0446 3.00E-04 ILMN_1219025 9030409G11Rik 71529 23254 Kazrin, periplakin interacting protein 297.6994 1.4891 0.0481 3.00E-04 ILMN_1251524 Them4 75778 117145 _1224363 Slc12a5 57138 57468 Solute carrier family 12, member 5 281.5906 1.6113 0.0347 3.00E-04 ILMN_1251998 Gm765 330390 NA Predicted gene 765 226.9486 1.6145 0.0249 1.00E-04 ILMN_2488510 Ppm1k 243382 152926 Protein phosphatase 1K (PP2C domain containing 308.258 1.6168 258.1943 1.6504 0.0299 2.00E-04 ILMN_2419660 mtDNA_ND4L NA NA NA 215.9199 1.6523 0.0237 1.00E-04 ILMN_1221817 Cd74 16149 972 CD74 antigen 308.2304 1.6595 0.0434 3.00E-04 ILMN_2545149 Nos1ap 70729 NA Nitric oxide synthase 1 (neuronal) adaptor protein 256. 8864 Period circadian clock 2 201.3209 1.677 0.0212 1.00E-04 ILMN_3157692 Ankrd35 213121 148741 Ankyrin repeat domain 35 310.3109 1.679 0.0432 3.00E-04 ILMN_1218471 3-Sep 24050 55964 Septin 3 229.1441 1.6798 0.0254 1.00E-04 ILMN_1229216 Zbtb16 235320 77 0.029 2.00E-04 ILMN_2466121 Twistnb 28071 221830 TWIST neighbor 250.5161 1.6978 0.029 2.00E-04 ILMN_2514631 scl0002315.1_12 217869 1983 Eukaryotic translation factor 5 186.3783 1.7007 0.0195 1.00E-04 ILMN_2493030 2310043N10Rik 66961 NA Nuclear paraspeckle assembly transcript 1 0.0184 1.00E-04 ILMN_2690603 Spp1 20750 6696 Secreted phosphoprotein 1 262.6651 1.7167 0.0313 2.00E-04 ILMN_2733314 Rgs7bp 52882 401190 Regulator of G-protein signaling 7 binding protein 218.5161 1.7173 0.0237 1.00E-04 ILMN_2593368 Mat2a 232087 4144 Methionine adeno family with sequence similarity 73, member A 224.4289 1.7346 0.0249 1.00E-04 ILMN_1233554 Pbrm1 66923 55193 Polybromo 1 215.0498 1.7355 0.0239 1.00E-04 ILMN_2669461 Bbx 70508 56987 Bobby sox homolog (Drosophila) 220.6021 1.7382 0.0238 1.00E-04 ILMN_1218712 Jp ILMN_1230605 Gm336 212285 116984 ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 172.8921 1.7587 0.0162 1.00E-04 ILMN_2803674 S100a9 20202 6280 S100 calcium binding protein A9 (calgranulin B) 192.6629 1.759 0.0213 1.00E-04 ILMN_3072536 Eif5 217869 1983 E k 78506 286097 Mitochondrial calcium uptake family, member 3 155.2155 1.7756 0.0142 0 ILMN_2571934 D030034I04Rik 105727 81539 Solute carrier family 38, member 1 176.004 1.7781 0.0166 1.00E-04 ILMN_1229727 Gpr123 52389 84435 G-protein-coupled receptor123 175.0744 1.7835 0.0164 1.00E asp-Glu-Ala-Asp box polypeptide 24 117.7708 1.806 0.0094 0 ILMN_2746797 Hsf4 26386 3299 Heat shock transcription factor 4 154.9416 1.8113 0.0141 0 ILMN_1227149 Meg3 17263 NA Maternally expressed 3 154.4618 1.8188 0.0141 0 ILMN_2544603 2610015J01Rik 6 LMN_2466797 scl0001284.1_18 NA NA NA 120.66 1.8657 0.0092 0 ILMN_2495555 Mapk8ip2 NA NA NA 110.3349 1.8716 0.008 0 ILMN_2720479 Lpgat1 226856 9926 Lysophosphatidylglycerol acyltransferase 1 107.1799 1.8815 0.008 0 ILMN pseudogene 1 99.2247 1.9029 0.0085 0 ILMN_2715848 Slitrk4 245446 139065 SLIT and NTRK-like family, member 4 104.8752 1.9033 0.0083 0 ILMN_2771709 Ppargc1b 170826 133522 Peroxisome proliferative-activated receptor, coactivator 1 93.2724 1.922 0.0076 0 ILMN_ 0 ILMN_2642426 Agmat 75986 79814 agmatine ureohydrolase (agmatinase) 45.5522 2.0743 0.0017 0 ILMN_1237548 5830407P18Rik NA NA 44.5367 2.0756 0.0018 0 ILMN_1259747 Il33 77125 90865 Interleukin-33 40.11 2.0942 0.001 0 ILM l1 71760 64850 Ethanolamine phosphate phospholyase 23.2317 2.4004 0 0 ILMN_2652500 Lrg1 76905 116844 Leucine-rich alpha-2-glycoprotein 1 11.5889 2.5107 0 0 ILMN_1229990 Agxt2l1 71760 64850 Ethanolamine phosphate phospholyase. DLA computes a linear regression between the molecular match score and the pathology score. large regression coefficients indicate that a given biological pathway is highly active in diseases that dysregulate plasticity gene signatures. each inflammation-related gene set was strongly associated with diseases that dysregulate the plasticity signature. seven of the 14 largest DLA associations were inflammation-related gene sets. each inflammation-related gene set in the hallmark library was strongly associated with diseases that dysregulate plasticity genes. inflammation is a process central to diseases predicted to dysregulate plasticity gene expression, suggesting that inflammation may disrupt developmental plasticity. bioinformatics analyses indicate inflammation is a process central to diseases predicted to dysregulate plasticity gene expression. 1244887 Gria4 NA NA NA 96.4906 1.5339 0.0229 0 ILMN_2649671 Ipas 53417 64344 Hypoxia-inducible factor 3, subunit 122.0152 1.5276 0.035 0 ILMN_2680188 Bai1 107831 575 Brain-specific angiogenesis inhibitor 1 137.2649 1.5013 0.04 0 ILMN_2968369 Kcnip1 70357 308 1.5191 0.0393 2.00E-04 ILMN_2491589 Vgll4 232334 9686 Vestigial like 4 (Drosophila) 311.6705 1.5218 0.0487 4.00E-04 ILMN_2568488 A530089A20Rik 218914 23063 Wings apart-like homolog (Drosophila) 300.5669 1.5221 0.0474 3.00E-04 ILMN_2768841 Rab22a ILMN_1257190 2900083I11Rik 58212 NA Serine/arginine repetitive matrix 3 269.2151 1.5392 0.0385 2.00E-04 ILMN_2639849 Cbln4 228942 140689 Cerebellin 4 precursor protein 290.2289 1.5404 0.0445 3.00E-04 ILMN_1255457 Crebbp 12914 1387 CREB binding protein 256.2379 1.5408 0.03 MACRO domain containing 2 298.574 1.5571 0.0468 3.00E-04 ILMN_1246494 LOC381445 26422 26960 Neurobeachin 240.5714 1.5576 0.0318 2.00E-04 ILMN_1225224 Ttc14 67120 151613 Tetratricopeptide repeat domain 14 257.4399 1.5601 0.0364 2.00E-04 ILMN_1259724 Man1b 17156 10905 Man meg3 17263 NA Maternally expressed 3 245.0182 1.579 0.032 2.00E-04 ILMN_2601176 Meg3 17263 NA Maternally expressed 3 246.2646 1.5793 0.0323 2.00E-04 ILMN_1230605 Gm336 212285 116984 ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 225.2295 1.5805 0.0309 1.00E-04 ILM 0293 1.00E-04 ILMN_1239599 Bat2d 226562 23215 Proline-rich coiled-coil 2C 218.0063 1.5911 0.0304 1.00E-04 ILMN_2637413 Dbpht2 386753 NA DNA binding protein with his-thr domain 185.7923 1.5957 0.023 1.00E-04 ILMN_1247295 Hook1 77963 51361 Hook homolog 1 (Drosophil 4a2 18227 4929 Nuclear receptor subfamily 4, group A, member 2 174.6364 1.6168 0.0212 1.00E-04 ILMN_1235652 Usp37 319651 57695 Ubiquitin-specific peptidase 37 190.4584 1.6202 0.0229 1.00E-04 ILMN_1255854 Mtap9 213582 79884 Microtubule-associated protein 9 183.2527 1.6215 0.0226 1 mgcs2 15360 3158 3-Hydroxy-3-methylglutaryl-coenzyme A synthase 2 189.7896 1.6367 0.0235 1.00E-04 ILMN_2646070 Mtap1a 17754 4130 Microtubule-associated protein 1 A 173.3318 1.6391 0.0212 1.00E-04 ILMN_1229727 Gpr123 52389 84435 G-protein-coupled receptor123 182.595 ILMN_1237548 5830407P18Rik NA NA NA 158.0665 1.6714 0.0161 0 ILMN_1220048 A330086O21Rik 434089 NA Predicted gene 10010 131.7096 1.672 0.0116 0 ILMN_1254296 Chd1 12648 1105 Chromodomain helicase DNA binding protein 1 134.8336 1.6821 0.0106 0 ILMN 0.0113 0 ILMN_2680128 Zc3h13 67302 NA Zinc finger CCCH type containing 13 80.5466 1.7652 0.0055 0 ILMN_1239042 Ankhd1 108857 54882 Ankyrin repeat and KH domain containing 1 86.1003 1.7765 0.0054 0 ILMN_3162820 Odz4 23966 26011 Teneurin transmembrane protein 4 coiled-coil containing protein kinase 2 65.4886 1.8737 0.0032 0 ILMN_2617920 1110017D15Rik 73721 84688 RIKEN cDNA 1110017D15 gene 48.1193 1.9436 0.0021 0 ILMN_1217776 Mll5 69188 55904 Lysine (K)-specific methyltransferase 2E 53.5131 1.9814 13654 1959 Early growth response 2 18.8649 2.4826 0.0014 0 ILMN_2652500 Lrg1 76905 116844 Leucine-rich alpha-2-glycoprotein 1 13.3721 2.4851 0 0 ILMN_2654906 Mgat3 17309 4248 Mannoside acetylglucosaminyltransferase 3 25.6626 2.6212 0.0012 0 ILMN_ mouse Entrez IDs were mapped to human orthologs using the mouse Genome Informatics homology reference to yield a 98 gene Lynx1/ plasticity signature. each inflammation-related gene set was strongly associated with plasticity. a total of 20,000 permutations of the gene sets were used to estimate p values and to normalize the regression coefficients. we hypothesized that inflammatory processes disrupt developmental cortical plasticity. a subset of genes from GSE3253 is likely to play a larger role in the under-lying biology (the genes in the extremes using a z-score cutoff) we identified a negative correlation in their expression pattern (cor = 0.77, p = 0.0007f, Spearman\u2019s correlation) among these shared genes, the adult LPS data indicated the direction of expression of 13 genes would be reversed by LPS. the expression of the 16 genes shared between juvenile plasticity and the LPS disease signatures is anticorrelated. the majority (8 of 13; 61.5%) showed a complete reversal in their differential expression pattern in V1 after LPS administration (300 g/kg LPS, intraperitoneally, at P26 during the peak of juvenile plasticity) ***p > 0.001 and 0.01, *p > 0.01 and 0.05 (two-sided t tests of CTs). Molecular matching among 436 disease signatures indicates diverse diseases may disrupt plasticity Rank Normalized molecular match score. 5078 Mus musculus Senescence Hippocampus 11 6.25 1.75E-06 5.46E-05 GSE4764 Mus musculus Yersinia enterocolitica food poisoning Peyer's patch 12 5.75 7.82E-07 3.40E-05 GSE4290 Homo sapiens Astrocytoma CNS, brain (MMHCC) 13 5.7 1.73E-05 3.59E-04 GSE1621 Mus musculus Bacterial infection mo sapiens Glioblastoma Brain 24 4.94 1.17E-04 1.13E-03 GSE1025 Mus musculus DMD Muscle, striated (skeletal) (MMHCC) 25 4.9 5.26E-05 6.95E-04 GSE1843 Rattus norvegicus Hepatic cirrhosis Hepatic tissue 26 4.86 1.54E-05 3.37E-04 GSE1572 Homo sapiens Senescence frontal cortex 27 4. cancer of colon Intestine, large intestine, colon (MMHCC) 38 4.54 1.20E-04 1.14E-03 GSE842 Mus musculus MS CNS, spinal cord (MMHCC) 39 4.53 8.18E-05 9.14E-04 GSE14905 Homo sapiens Psoriasis vulgaris Skin tissue 40 4.51 3.40E-05 5.29E-04 GSE7305 Homo sapiens Endometriosis Endometrium 41 66E-04 2.11E-03 GSE2052 Homo sapiens Idiopathic fibrosing alveolitis Lung tissue 52 4 2.23E-04 1.83E-03 GSE1873 Mus musculus Obstructive sleep apnea Hepatic tissue 53 3.97 4.39E-04 3.07E-03 GSE4183 Homo sapiens IBD Colon 54 3.96 1.01E-04 1.02E-03 GSE3075 Mus musculus GSE3678 Homo sapiens Papillary carcinoma of the thyroid Thyroid gland (MMHCC) 65 3.74 4.88E-04 3.18E-04 3.18E-03 GSE4619 Homo sapiens MDS Bone marrow stem cell 66 3.73 5.92E-04 3.51E-03 GSE3112 Homo sapiens Polymyositis Muscle tissue 67 3.72 3.51E-04 2.59E-03 GSE3189 Homo sapiens Multiple benign 26 Mus musculus Bruton's agammaglobulinemia B-cell lymphocyte 78 3.54 7.46E-04 4.17E-03 GSE2640 Mus musculus Pulmonary fibrosis Lung tissue 79 3.53 5.37E-04 3.35E-03 GSE2514 Homo sapiens Adenocarcinoma of lung Lung tissue 80 3.53 8.90E-04 4.73E-03 GSE1551 Homo sapiens Derma 9.16E-03 GSE4390 Mus musculus ALS CNS, spinal cord (MMHCC) 90 3.38 1.21E-03 5.87E-03 GSE3644 Mus musculus Acute pancreatitis Pancreas 91 3.38 1.30E-03 6.16E-03 GSE3112 Homo sapiens Inclusion body myositides Muscle tissue 92 3.33 1.10E-03 5.58E-03 GSE466 Mus arynx epithelium 102 3.17 1.40E-03 6.36E-03 GSE13355 Homo sapiens Psoriasis vulgaris Skin tissue 103 3.15 2.20E-03 9.50E-03 GSE2866 Mus musculus -Hydroxybutyric acidemia Cerebral cortex 104 3.12 2.60E-03 1.08E-02 GSE4911 Mus musculus Cleidocranial dysostos aryocyte 115 2.93 4.60E-03 1.71E-02 GSE1776 Mus musculus Nutritional deficiency, NEC Skeletal myocyte 116 2.93 3.90E-03 1.49E-02 GSE4587 Homo sapiens In situ melanoma of skin Epidermis 117 2.92 5.30E-03 1.88E-02 GSE9579 Homo sapiens Appendicitis Appendix 118 2.91 5.80 bowel syndrome variant of childhood with diarrhea Sigmoid colon 128 2.72 8.40E-03 2.75E-02 GSE2779 Homo sapiens MDS Bone marrow stem cell 129 2.72 7.20E-03 2.43E-02 GSE1947 Mus musculus Peripheral motor neuropathy Sciatic nerve 130 2.71 8.40E-03 2.75E-02 GSE593 Homo sapiens Uterine leiomyoma Uterus, stromal tumor Connective tissue 140 2.59 9.60E-03 3.01E-02 GSE7036 Homo sapiens Bipolar disorder Lymphocyte 141 2.57 1.00E-02 3.07E-02 GSE1724 Homo sapiens Scleroderma Fibroblast 142 2.56 9.70E-03 3.02E-02 GSE3790 Homo sapiens Huntington's disease Caudate nucleus 143 2.55 1.25E-02 3.68E-02 G 02E-02 GSE3418 Mus musculus Lung transplant rejection Trachea 154 2.47 1.45E-02 4.11E-02 EXPE-MEXP-476 Homo sapiens Cancer of prostate Endothelial cell 155 2.47 1.54E-02 4.28E-02 GSE3184 Mus musculus Asthma, allergic Lung tissue 156 2.46 1.49E-02 4.16E-02 GSE4616 Mus musculus Type -02 GSE3248 Mus musculus Huntington's disease CNS, brain, cerebellum (MMHCC) 167 2.25 2.42E-02 6.28E-02 GSE4788 Mus musculus Parkinson's disease Substantia nigra 168 2.24 2.52E-02 6.46E-02 GSE4710 Mus musculus Heart injury Myocardial tissue 169 2.21 2.52E-02 6.46E-02 GSE63 Sigmoid colon 179 2.08 3.69E-02 8.99E-02 GSE4130 Rattus norvegicus Dehydration Pituitary gland 180 2.07 3.72E-02 9.01E-02 GSE9006 Homo sapiens Type 2 diabetes mellitus Peripheral blood mononuclear cell 181 2.06 4.00E-02 9.40E-02 GSE2899 Mus musculus Type 2 diabetes mellitus Soleus muscle Homo sapiens HIV encephalitis frontal cortex 192 2 4.44E-02 1.01E-01 GSE3203 Mus musculus Influenza B-cell lymphocyte 193 1.99 4.67E-02 1.05E-01 GSE2559 Homo sapiens Pulmonary hypertension, primary Pulmonary artery 194 1.98 4.76E-02 1.06E-01 GSE3807 Homo sapiens Aplastic anemia Bone marrow 195 1.98 4.85E 61E-02 1.18E-01 GSE5538 Mus musculus Hepatic lipidosis Hepatic Tissue 206 1.9 5.37E-02 1.16E-01 EXPE-MEXP-692 Homo sapiens Barrett esophagus Esophagus 207 1.9 5.60E-02 1.18E-01 GSE1659 Mus musculus Type 1 diabetes mellitus Muscle, striated (skeletal) 208 1.89 6.00 70E-02 1.54E-01 GSE9800 Homo sapiens Cardiomyopathy, dilated Myocardial tissue 218 1.71 8.68E-02 1.70E-01 GSE3915 Mus musculus Cancer of the intestine Small bowel 219 1.69 9.30E-02 1.80E-01 GSE5581 Mus musculus Retinoschisis Retina 220 1.68 8.96E-02 1.75E-01 GSE868 Mus ary epithelium 231 1.55 1.15E-01 2.13E-01 GSE3320 Homo sapiens COPD Bronchial epithelium 232 1.55 1.19E-01 2.17E-01 GSE5774 Homo sapiens Nonspecific interstitial pneumonia Lung tissue 233 1.55 1.18E-01 2.16E-01 GSE6710 Homo sapiens Psoriasis vulgaris Skin tissue 234 1.53 1.29E-01 2.31E-01 GSE42 ocyte 245 1.45 1.38E-01 2.42E-01 GSE4302 Homo sapiens Asthma Epithelial cell 246 1.45 1.44E-01 2.50E-01 GSE5370 Homo sapiens Dermatomyositis Muscle, striated (skeletal) (MMHCC) 247 1.42 1.53E-01 2.61E-01 GSE2172 Mus musculus Colitis Intestine, large intestine, colon (MMHCC) 2 258 1.32 1.83E-01 2.98E-01 GSE3790 Homo sapiens Huntington's disease CNS, brain, cerebellum (MMHCC) 259 1.31 1.87E-01 3.03E-01 GSE2503 Homo sapiens Actinic keratosis Skin tissue 260 1.29 1.94E-01 3.12E-01 GSE1010 Homo sapiens Familial combined hyperlipidemia Lymphoblast 261 1.27 2.00E-01 3.17 50E-01 3.78E-01 EXPE-MEXP-669 NULL Neuroblastoma Adrenal cortex 273 1.12 2.62E-01 3.95E-01 GSE3889 Mus musculus Hypercholesterolemia Hepatic tissue 274 1.11 2.66E-01 3.97E-01 GSE2175 Homo sapiens Adenoma of pituitary gland Pituitary gland 275 1.1 2.71E-01 4.03E-01 GSE3925 Mus muscul 22E-01 4.62E-01 GSE10964 Mus musculus COPD Lung 287 0.99 3.28E-01 4.69E-01 GSE2657 Homo sapiens Sarcoidosis T lymphocyte 288 0.96 3.41E-01 4.81E-01 GSE1767 Homo sapiens Huntington's disease Blood 289 0.96 3.35E-01 4.77E-01 GSE7753 Homo sapiens JRA Peripheral blood mononuclear cell 290 0.95 iens Androgen insensitivity syndrome Fibroblast 301 0.81 4.17E-01 5.63E-01 GSE1606 Mus musculus Turner syndrome CNS, brain (MMHCC) 302 0.8 4.27E-01 5.70E-01 GSE3195 Mus musculus hypoxia Fibroblast 304 0.79 4.28E-01 5.70E-01 GSE475 Homo sapiens COPD Muscle, striated (skeletal), diaphragm (MMHCC) 305 -476 Homo sapiens Cancer of prostate Endothelial cell 315 0.66 5.10E-01 6.54E-01 GSE9877 Homo sapiens Sickle cell anemia Endothelial cell 316 0.65 5.18E-01 6.62E-01 GSE3026 Homo sapiens Bacterial infection Peripheral blood mononuclear cell 317 0.63 5.30E-01 6.76E-01 GSE128 Mus musculus Retinitis pigment ocardial tissue 328 0.56 5.74E-01 7.03E-01 GSE1008 Mus musculus DMD Extraocular muscle 329 0.53 5.90E-01 7.15E-01 GSE1472 Mus musculus APECED Thymic epithelial cell 331 0.53 5.92E-01 7.15E-01 GSE1849 Homo sapiens Sickle cell anemia Pulmonary artery 332 0.52 5.99E-01 7.19E-01 GSE3311 Rat 7.97E-01 GSE9692 Homo sapiens Septic shock Whole blood 343 0.38 7.10E-01 8.01E-01 GSE6740 Homo sapiens HIV T lymphocyte 344 0.36 7.13E-01 8.03E-01 GSE121 Homo sapiens Type 2 diabetes mellitus Muscle tissue 345 0.36 7.25E-01 8.14E-01 GSE1402 Homo sapiens Spondyloarthropathy Peripheral blood mononuclear cell musculus Obesity Adipose tissue 357 0.12 9.02E-01 9.43E-01 GSE3249 Mus musculus Leber congenital amaurosis Retina 358 0.12 9.02E-01 9.43E-01 GSE1852 Mus musculus Marfan\u2019s syndrome Myocardial tissue 359 0.08 9.34E-01 9.66E-01 GSE7654 Rattus norvegicus Hepatitis Liver 360 0.08 9.35 idiopathic thrombocytopenic T lymphocyte 372 0.02 9.80E-01 9.89E-01 GSE3827 Homo sapiens CBCL Skin tissue 373 0.03 9.76E-01 9.89E-01 GSE8835 Homo sapiens B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma Peripheral blood mononuclear cell 374 0.07 9.42E-01 9.66E-01 GSE2779 Hom 384 0.2 8.46E-01 9.08E-01 GSE4036 Homo sapiens Schizophrenia CNS, brain, cerebellum (MMHCC) 385 0.22 8.27E-01 8.93E-01 GSE14245 Homo sapiens Malignant tumor of pancreas Saliva 386 0.24 8.06E-01 8.72E-01 GSE2459 Mus musculus Hypertrophy, left ventricular Myocardial tissue 387 0.29 7.69E-01 8.44 o sapiens Psoriasis vulgaris Epidermis 398 0.41 6.78E-01 7.81E-01 GSE2729 Homo sapiens Rotavirus infection of children Peripheral blood mononuclear cell 399 0.41 6.78E-01 7.81E-01 GSE14577 Homo sapiens CFS Peripheral blood mononuclear cell 400 0.43 6.66E-01 7.74E-01 GSE363 Mus musculus Atherosclerosis He Lung tissue 411 0.63 5.34E-01 6.77E-01 GSE1907 Homo sapiens Sarcoidosis Blood corpuscle 412 0.7 4.74E-01 6.17E-01 GSE3100 Mus musculus Cystic fibrosis Lung 413 0.74 4.62E-01 6.07E-01 GSE7277 Mus musculus Arthritis frontal cortex 414 0.85 3.97E-01 5.39E-01 GSE3384 Mus musculus Nemal leukocyte 424 1.28 2.01E-01 3.18E-01 GSE3512 Rattus norvegicus Hyperlipidemia Hepatic tissue 425 1.29 1.97E-01 3.16E-01 EXPE-MEXP-357 Rattus norvegicus Hypertension Left ventricle 426 1.36 1.75E-01 2.88E-01 GSE4630 Homo sapiens Hypoxia macrophage 427 1.38 1.68E-01 2.80E-01 GSE1294 Mus we computationally matched the juvenile plasticity signature to 436 disease signatures derived from public microarray data. high scores indicate that plasticity genes are significantly dysregulated by the disease. low scores indicate that the disease has no impact on plasticity genes. inflammation induced by LPS suppresses experience-dependent plasticity in juvenile cortex. a, Juvenile mice (P26) during peak of ocular dominance plasticity were injected intraperitoneally with either LPS (300 g/kg) or saline. animal-level quantification of ocular dominance plasticity by CBI reflects extent of ocular dominance shift after 3 d of MD. CBI was strongly increased in the LPS-treated group compared with saline-treated group (gray discs: CBI = 0.64 0.02, 7 mice) qPCR data are reported as the mean SEM. ical responsivity from the deprived contralateral eye to the nondeprived ipsilateral eye was quantified by an increase in CBI and an elimination of the right shift in the distribution of ODSs of single neurons. these data are consistent with our informatics-derived hypothesis by demonstrating that peripheral injection of LPS induces an inflammatory response in the brain and suppresses developmental cortical plasticity in vivo. non-neurologic disorders suggest broad range of disease states may impact molecular pathways involved in plasticity. a, b, Juvenile plasticity signature of 176 genes (represented by green bars) was computationally matched to 436 disease signatures (represented by orange bars; a) using rank-based molecular matching. protein 61 13.632 2.5389 0 0 ILMN_1251414 Npas4 225872 266743 Neuronal PAS domain protein 4 28.3181 2.375 0 0 ILMN_2597827 Arc 11838 23237 Activity-regulated cytoskeletal-associated protein 15.7472 2.3415 0 0 ILMN_1230397 A630064P09Rik NA NA 15.7373 2.331 0 0 ILMN_ 0 0 ILMN_2707616 Col22a1 69700 169044 Collagen, type XXII, alpha 1 32.3997 1.9656 0 0 ILMN_1221178 Pdlim2 213019 64236 PDZ and LIM domain 2 38.5983 1.9267 5.00E-04 0 ILMN_2463181 Tnc 21923 3371 Tenascin C 37.2206 1.9239 5.00 766894 Enpp6 320981 133121 Ectonucleotide pyrophosphatase/phosphodiesterase 6 60.0087 1.7971 8.00E-04 0 ILMN_1223244 Hbb-b1 NA NA 71.2786 1.7908 0.0012 0 ILMN_2906855 Ky 16716 339855 Kyphoscoliosis peptidase 63.327 1.7828 7.00E-04 0 I 7826 1.7239 0.0024 0 ILMN_1242456 Kank1 107351 23189 KN motif and ankyrin repeat domains 1 82.1412 1.7197 0.0026 0 ILMN_1237021 Mag 17136 4099 Myelin-associated glycoprotein 107.5658 1.7077 0.0049 0 ILMN_2675874 Alas2 11656 212 Aminolevulinic acid synthase 85 Trp53inp2 68728 58476 Transformation-related protein 53-inducible nuclear protein 2 127.672 1.6497 0.0091 0 ILMN_2977558 Dapk2 13143 23604 Death-associated protein kinase 2 115.4908 1.6484 0.0078 0 ILMN_2777359 Serpinh1 12406 871 Serine (or cysteine) peptidase inhibitor, member 1 13 0.0379 2.00E-04 ILMN_2623983 Egr2 13654 1959 Early growth response 2 167.9258 1.6117 0.0141 1.00E-04 ILMN_2506428 Ky 16716 339855 Kyphoscoliosis peptidase 149.169 1.6067 0.0109 0 ILMN_2545963 Hbb-b1 NA NA NA 147.5637 1.6053 0.0108 0 ILMN 0.0157 1.00E-04 ILMN_1258028 Gal3st1 53897 9514 Galactose-3-O-sulfotransferase 1 168.0194 1.5754 0.0139 1.00E-04 ILMN_2621544 2700060E02Rik 18074 22795 Nidogen 2179.1935 1.5706 0.0159 1.00E-04 ILMN_2711163 Ctsk 13038 1513 Cat protein 2 202.9992 1.5454 0.0207 1.00E-04 ILMN_2650447 Col23a1 237759 91522 Collagen, type XXIII, alpha 1 215.8733 1.545 0.0231 1.00E-04 ILMN_1239117 Hbb-b1 NA NA 221.9056 1.5432 0.0251 1.00E-04 ILMN_2638473 1190003M12Rik 68888 NA Gastrokine 3 1 18140 29128 Ubiquitin-like, containing PHD and RING finger domains, 1 280.3468 1.5086 0.0429 3.00E-04 ILMN_1241168 Dok4 114255 55715 Docking protein 4 254.0057 1.5079 0.0341 2.00E-04 ILMN_2625854 2310016C16Rik 69590 493869 Glutathione peroxidase 8 (putative) 256 N_2737479 Slc12a9 83704 56996 Solute carrier family 12 (potassium/chloride transporters), member 9 274.5651 1.4905 0.041 3.00E-04 ILMN_1257097 Cnp 12799 1267 2',3'-cyclic nucleotide 3' phosphodiesterase 288.7593 1.4897 0.0446 3.00E-04 ILMN_1219025 9030409G11R 5755 0.0398 3.00E-04 ILMN_2775885 Calm2 12314 NA Calmodulin 2 278.2959 1.5868 0.0343 2.00E-04 ILMN_1224363 Slc12a5 57138 57468 Solute carrier family 12, member 5 281.5906 1.6113 0.0347 3.00E-04 ILMN_1251998 Gm765 330390 NA Predicted gene 765 226.9486 1.6145 ductase domain containing 1 253.0893 1.6455 0.0299 2.00E-04 ILMN_2445958 Tssc8 63830 NA KCNQ1 overlapping transcript 1 258.1943 1.6504 0.0299 2.00E-04 ILMN_2419660 mtDNA_ND4L NA NA NA 215.9199 1.6523 0.0237 1.00E-04 ILMN_1221817 Cd74 16149 972 CD74 antigen ( Fnip1 216742 96459 Folliculin-interacting protein 1 269.2034 1.6764 0.033 2.00E-04 ILMN_2987863 Per2 18627 8864 Period circadian clock 2 201.3209 1.677 0.0212 1.00E-04 ILMN_3157692 Ankrd35 213121 148741 Ankyrin repeat domain 35 310.3109 1.679 0.0432 3.00E-04 ILMN_12 57 1.6935 0.0347 3.00E-04 ILMN_2589525 Cpeb3 208922 22849 Cytoplasmic polyadenylation element binding protein 3 277.0563 1.6955 0.0345 2.00E-04 ILMN_2466121 Twistnb 28071 221830 TWIST neighbor 250.5161 1.6978 0.0345 2.00E-04 ILMN_2514631 scl0002315.1_12 217869 2762701 Scn1a 20265 6323 Sodium channel, voltage-gated, type I, alpha 235.4555 1.7097 0.0263 2.00E-04 ILMN_1243910 Zfp292 30046 23036 Zinc finger protein 292 182.6041 1.71 0.0184 1.00E-04 ILMN_2690603 Spp1 20750 6696 Secret phosphoprotein 1 262.6651 1.7167 0.0313 2.00E-04 I 173 269589 84958 Synaptotagmin-like 1 233.1724 1.7313 0.0262 2.00E-04 ILMN_2713004 C030011O14Rik 215708 374986 Family with sequence similarity 73, member A 224.4289 1.7346 0.0249 1.00E-04 ILMN_1233554 Pbrm1 66923 55193 Polybromo 1 215.0498 1.7355 0.0239 1.00 ILMN_2541675 LOC382128 319675 85459 gene 225.9716 1.7473 0.0251 1.00E-04 ILMN_1230605 Gm336 212285 116984 ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 172.8921 1.7587 0.0162 1.00E-04 ILMN_2803674 S100a9 20202 6280 S100 calcium binding protein A9 (calgran 0.0155 1.00E-04 ILMN_1220828 2900075B16Rik 78506 286097 Mitochondrial calcium uptake family, member 3 155.2155 1.7756 0.0142 0 ILMN_2571934 D030034I04Rik 105727 81539 Solute carrier family 38, member 1 176.004 1.7781 0.0166 1.00E-04 ILMN_1229727 Gpr123 52389 84435 G 12 106585 23253 ankyrin repeat domain 12 159.7083 1.8008 0.0149 0 ILMN_2747381 Ddx24 27225 57062 DEAD (Asp-Glu-Ala-Asp) box polypeptide 24 117.7708 1.806 0.0094 0 ILMN_2746797 Hsf4 26386 3299 Heat shock transcription factor 4 154.9416 1.8113 0.0141 0 ILMN_1217776 Mll5 69188 55904 Lysine (K)-specific methyltransferase 2E 123.3913 1.8632 0.0097 0 ILMN_2466797 scl0001284.1_18 NA NA 120.66 1.8657 0.0092 0 ILMN_2495555 Mapk8ip2 NA NA 110.3349 1.8716 0.008 0 ILMN_2720479 Lp Espin 150.8775 1.9026 0.0136 0 ILMN_1245389 LOC236604 236604 NA Phosphatidylserine decarboxylase, pseudogene 1 99.2247 1.9029 0.0085 0 ILMN_2715848 Slitrk4 245446 139065 SLIT and NTRK-like family, member 4 104.8752 1.9033 0.0083 0 ILMN_27158 145 0.0018 0 ILMN_1236844 A830094I09Rik NA NA NA NA 55.3183 2.0239 0.0021 0 ILMN_2432200 Epb4.1 NA NA NA 49.8425 2.0396 0.0023 0 ILMN_2642426 Agmat 75986 79814 agmatine ureohydrolase (agmatinase) 45.5522 2.0743 0.0017 0 ILMN RankProd differential expression (DE) analysis compared mice with adult mice with naturally elevated experience-dependent plasticity to generate the juvenile plasticity differential expression signature. n = 3 each group mapped to 193 unique mouse Entrez IDs using the mouse Genome Informatics homology reference. DLA calculates the association between diseases that dysregulate plasticity signatures and the 50 gene sets in the hallmark library that represent well defined and distinct biological pathways. a given biological pathway is highly active in diseases that dysregulate plasticity gene signatures. plasticity signature genes and 50 well defined and distinct biological pathways. to do so, it computes a regression between the molecular match score and the pathology score. each inflammation-related gene set was strongly associated with diseases that dysregulate plasticity. x1/ plasticity signatures significantly overlap (35 genes shared, OR = 37.1, 95% CI = 23.8\u201358.0, p 2.2 1016b) the bioinformatics analyses indicate that inflammation is a process central to diseases predicted to dysregulate plasticity gene expression. 98.106 1.5481 0.0213 0 ILMN_1251713 Car12 76459 771 Carbonic anyhydrase 12 94.6178 1.5436 0.032 0 ILMN_1244887 Gria4 NA NA NA 96.4906 1.5339 0.0229 0 ILMN_2649671 Ipas 53417 64344 Hypoxia-inducible factor 3, subunit 122.0152 1.5276 0.035 0 ILMN_26 307.0792 1.5179 0.0488 3.00E-04 ILMN_2869715 Nell2 54003 4753 NEL-like 2 277.2855 1.5191 0.0393 2.00E-04 ILMN_2491589 Vgll4 232334 9686 Vestigial like 4 (Drosophila) 300.5669 1.5221 0.0474 3.00E-04 ILMN_2768841 Rab22a NA NA 312.3161 1.5221 0. 3151149 Cpne8 66871 144402 Copine VIII 273.9191 1.5385 0.0391 2.00E-04 ILMN_2657911 Cnot4 53621 4850 CCR4-NOT transcription complex, subunit 4 309.8885 1.5389 0.049 3.00E-04 ILMN_1257190 2900083I11Rik 58212 NA Serine/arginine repetitive matrix 3 269.2151 1.5392 0.0385 2.00 repeat domain 12 267.3929 1.5547 0.0379 2.00E-04 ILMN_2703913 Mtf2 17765 22823 Metal response element binding transcription factor 2 218.0454 1.5569 0.03 1.00E-04 ILMN_2535881 Macrod2 72899 140733 MACRO domain containing 2 298.574 1.5571 0.0468 3.00E-04 ILMN_1246494 LOC381445 26422 26960 Neurobeachin 47.466 1.5728 0.0324 2.00E-04 ILMN_2731854 Creg2 263764 200407 Cellular repressor of E1A-stimulated genes 2 218.4269 1.5755 0.0297 1.00E-04 ILMN_1221598 9330133O14Rik NA NA NA 259.2859 1.578 0.0363 2.00E-04 ILMN_1227149 Meg3 17263 NA Maternally expressed 3 245.0 brand factor homolog 194.1056 1.5868 0.0229 1.00E-04 ILMN_1215713 Egr4 13656 1961 Early growth response 4 220.9951 1.5896 0.0293 1.00E-04 ILMN_1239599 Bat2d 226562 23215 Proline-rich coiled-coil 2C 218.0063 1.5911 0.0304 1.00E-04 ILMN_2637413 Dbpht2 386753 NA DNA binding ILMN_2737867 Mtap1b 17755 4131 Microtubule-associated protein 1B 219.8212 1.616 0.0296 1.00E-04 ILMN_1254547 Nr4a2 18227 4929 Nuclear receptor subfamily 4, group A, member 2 174.6364 1.6168 0.0212 1.00E-04 ILMN_1235652 Usp37 319651 57695 Ubiquitin-specific peptidase 37 190. 0.0229 1.00E-04 ILMN_2795040 Hist1h2ad NA NA 189.467 1.6364 0.0239 1.00E-04 ILMN_1216322 Hmgcs2 15360 3158 3-Hydroxy-3-methylglutaryl-coenzyme A synthase 2 189.7896 1.6367 0.0235 1.00E-04 ILMN_2646070 Mtap1a 17754 4130 Microtubule 67 284695 Zinc finger protein 326 134.6324 1.67 0.0109 0 ILMN_1257525 Cpeb3 208922 22849 Cytoplasmic polyadenylation element binding protein 3 135.784 1.6706 0.0108 0 ILMN_1237548 5830407P18Rik NA NA NA 158.0665 1.6714 0.0161 0 ILMN_1220048 A330086O21Rik 4 ILMN_2675914 R3hdm1 226412 23518 R3H domain containing 1 124.2134 1.7587 0.0113 0 ILMN_2680128 Zc3h13 67302 NA Zinc finger CCCH type containing 13 80.5466 1.7652 0.0055 0 ILMN_1239042 Ankhd1 108857 54882 Ankyrin repeat and KH domain containing 1 86.1003 1. _2803674 S100a9 20202 6280 S100 calcium-binding protein A9 (calgranulin B) 73.6082 1.8653 0.0057 0 ILMN_2639442 Rock2 19878 9475 Rho-associated coiled-coil containing protein kinase 2 65.4886 1.8737 0.0032 0 ILMN_2617920 1110017D15Rik 73721 84688 RIKEN eoglycan 4 (megakaryocyte stimulating factor, articular superficial zone protein) 61.9241 2.1057 0.0033 0 ILMN_2623983 Egr2 13654 1959 Early growth response 2 18.8649 2.4826 0.0014 0 ILMN_2652500 Lrg1 76905 116844 Leucine-rich alpha-2-glycoprotein 1 13.3721 2.4851 0 0 ILMN_2 DLA systematically identified biological processes associated with diseases that dysregulate the adult Lynx1/ plasticity signature. 132 DE probes mapped to 107 unique mouse Entrez IDs. each inflammation-related gene set in the hallmark library was strongly associated with diseases that dysregulate plasticity genes. a total of 20,000 permutations of the gene sets were used to estimate p values. molecular match between the juvenile plasticity signature and an adult brain-derived LPS transcriptome. we identified a subset of genes from GSE3253 that is likely to play a larger role in the under-lying biology. among these shared genes, the adult LPS data indicated the direction of expression of 13 genes would be reversed by LPS. predicted in silico to decrease after LPS compared with vehicle. other known plasticity effectors were not changed relative to vehicle. a, LPS disease signature shares plasticity signature genes in silico. regulated Cldn5 and Slc40a1 and upregulated Alox12b, S100a9a, Ch25h, Lrg1, S100a8, and Lcn2 (n = 5 mice per group). ***p 0.001, **p > 0.001 and 0.01, *p > 0.01 and 0.05 (two-sided t tests of CTs). myocardial tissue 9 6.47 8.10E-07 3.40E-05 GSE5389 Homo sapiens Bipolar disorder frontal cortex 10 6.33 8.15E-07 3.40E-05 GSE5078 Mus musculus Senescence Hippocampus 11 6.25 1.75E-06 5.46E-05 GSE4764 Mus musculus Yersinia enterocolitica food poisoning Peyer's patch 12 5.75 7.82E-07 3.40E-05 E-04 GSE464 Rattus norvegicus Spinal cord injury CNS, spinal cord (MMHCC) 23 4.98 1.87E-05 3.71E-04 EXPE-MEXP-567 Homo sapiens Glioblastoma Brain 24 4.94 1.17E-04 1.13E-03 GSE1025 Mus musculus DMD Muscle, striated (skeletal) (MMHCC) 25 4.9 5.26E-05 6.95E-04 G mo sapiens Papillary carcinoma of the thyroid Thyroid gland (MMHCC) 36 4.57 3.84E-05 5.49E-04 GSE3621 Mus musculus Huntington's disease Brain 37 4.56 3.35E-05 5.29E-04 GSE4107 Homo sapiens Cancer of colon Intestine, large intestine, colon (MMHCC) 38 4.54 1.20E-04 1.14E-03 GSE842 Mus musculus MS CNS, spinal cord (MM brain 51 4.01 2.66E-04 2.11E-03 GSE2052 Homo sapiens Idiopathic fibrosing alveolitis Lung tissue 52 4 2.23E-04 1.83E-03 GSE1873 Mus musculus Obstructive sleep apnea Hepatic tissue 53 3.97 4.39E-04 3.07E-03 GSE4183 Homo sapiens IBD Colon 54 3.96 1.01E-04 1.02E-03 GSE3075 Mus E-04 4.92E-03 GSE1026 Mus musculus DMD Muscle, striated (skeletal), diaphragm (MMHCC) 64 3.79 5.25E-04 3.35E-03 GSE3678 Homo sapiens Papillary carcinoma of the thyroid Thyroid gland (MMHCC) 65 3.74 4.88E-04 3.18E-03 GSE4619 Homo sapiens MDS Bone marrow stem cell 66 3.73 5.92E-04 3.51 5.87E-03 GSE977 Mus musculus Alexander disease CNS, brain, olfactory bulb (MMHCC) 77 3.55 5.37E-04 3.35E-03 GSE2826 Mus musculus Bruton's agammaglobulinemia B-cell lymphocyte 78 3.54 7.46E-04 4.17E-03 GSE2640 Mus musculus Pulmonary fibrosis Lung tissue 79 3.53 5.37E-04 3.4 6.73E-04 3.91E-03 GSE9375 Mus musculus Huntington's disease CNS, brain, striatum (MMHCC) 89 3.39 2.10E-03 9.16E-03 GSE4390 Mus musculus ALS CNS, spinal cord (MMHCC) 90 3.38 1.21E-03 5.87E-03 GSE3644 Mus musculus Acute pancreatitis Pancreas 91 3.38 1.30 disorder associated with type 2 diabetes mellitus Mesangial cell 101 3.18 1.40E-03 6.36E-03 GSE3524 Homo sapiens Squamous cell carcinoma of mouth Oropharynx epithelium 102 3.17 1.40E-03 6.36E-03 GSE13355 Homo sapiens Psoriasis vulgaris Skin tissue 103 3.15 2.20E-03 9.50E-03 GSE2866 Mus musculus -H Thrombocytopenia Megakaryocyte 114 2.99 4.30E-03 1.62E-02 GSE2433 Mus musculus Leukemia, acute megakaryocytic Megakaryocyte 115 2.93 4.60E-03 1.71E-02 GSE1776 Mus musculus Nutritional deficiency, NEC Skeletal myocyte 116 2.93 3.90E-03 1.49E-02 GSE4587 Homo sapiens In situ 44 Homo sapiens Glaucoma Astrocyte 127 2.79 6.20E-03 2.13E-02 EXPE-TABM-176 Homo sapiens Irritable bowel syndrome variant of childhood with diarrhea Sigmoid colon 128 2.72 8.40E-03 2.75E-02 GSE2779 Homo sapiens MDS Bone marrow stem cell 129 2.72 7.20E-03 2.43E-02 GSE1947 Mus muscul 02 GSE1375 Mus musculus Alzheimer's disease Cerebral cortex 139 2.59 9.80E-03 3.03E-02 GSE2719 Homo sapiens Gastrointestinal stromal tumor Connective tissue 140 2.59 9.60E-03 3.01E-02 GSE7036 Homo sapiens Bipolar disorder Lymphocyte 141 2.57 1.00E-02 3.07E-02 GSE1724 Homo sapiens Scleroderma Fibroblast 142 ia nigra 152 2.48 1.35E-02 3.92E-02 GSE10971 Homo sapiens Serous carcinoma Fallopian tube 153 2.48 1.40E-02 4.02E-02 GSE3418 Mus musculus Lung transplant rejection Trachea 154 2.47 1.45E-02 4.11E-02 EXPE-MEXP-476 Homo sapiens Cancer of prostate Endothelial cell 155 2.47 1.54E-02 2.29E-02 6.01E-02 GSE10921 Homo sapiens Idiopathic fibrosing alveolitis Fibroblast 166 2.26 2.41E-02 6.28E-02 GSE3248 Mus musculus Huntington's disease CNS, brain, cerebellum (MMHCC) 167 2.25 2.42E-02 6.28E-02 GSE4788 Mus musculus Parkinson's disease Substantia nigra 168 thrombocythemia Megakaryocyte 178 2.09 3.92E-02 9.39E-02 EXPE-TABM-176 Homo sapiens Irritable bowel syndrome variant of childhood with constipation Sigmoid colon 179 2.08 3.69E-02 8.99E-02 GSE4130 Rattus norvegicus Dehydration Pituitary gland 180 2.07 3.72E-02 9.01E-02 GSE9006 Homo sap 1.01E-01 GSE2254 Mus musculus Type 1 diabetes mellitus pancreatic islet 191 2 4.57E-02 1.03E-01 GSE3489 Homo sapiens HIV encephalitis frontal cortex 192 2 4.44E-02 1.01E-01 GSE3203 Mus musculus Influenza B-cell lymphocyte 193 1.99 4.67E-02 1.05E-01 GSE2559 Homo sapiens Pulmonary hypertension, primary Pulmon matopoietic stem cell 204 1.91 5.56E-02 1.18E-01 GSE11208 Homo sapiens Nicotine addiction Ganglioneuroblastoma 205 1.91 5.61E-02 1.18E-01 GSE5538 Mus musculus Hepatic lipidosis Hepatic Tissue 206 1.9 5.37E-02 1.16E-01 EXPE-MEXP-692 Homo sapiens Barrett esophagus Esophagus myocardial tissue 216 1.76 8.01E-02 1.59E-01 GSE3790 Homo sapiens Huntington's disease frontal cortex 217 1.76 7.70E-02 1.54E-01 GSE9800 Homo sapiens Cardiomyopathy, dilated Myocardial tissue 218 1.71 8.68E-02 1.70E-01 GSE3915 Mus musculus Cancer of the intestine Small bowel 219 1.69 9.30E-02 1.80E -01 2.01E-01 GSE2155 Homo sapiens Breast cancer Epithelial cell 230 1.56 1.18E-01 2.16E-01 GSE1299 Homo sapiens Breast cancer Mammary epithelium 231 1.55 1.15E-01 2.13E-01 GSE3320 Homo sapiens COPD Bronchial epithelium 232 1.55 1.19E-01 2.17E-01 GSE5774 Homo sapiens Nonspecific interstitial pneumonia Lung tissue intestine Intestinal epithelium 244 1.46 1.41E-01 2.46E-01 EXPE-TABM-36 Homo sapiens Hepatocellular adenoma Hepatocyte 245 1.45 1.38E-01 2.42E-01 GSE4302 Homo sapiens Asthma Epithelial cell 246 1.45 1.44E-01 2.50E-01 GSE5370 Homo sapiens Dermatomyositis Muscle, striated (skeletal thrombocythemia Megakaryocyte 257 1.32 1.91E-01 3.09E-01 GSE6798 Homo sapiens Polycystic ovary syndrome Skeletal muscle 258 1.32 1.83E-01 2.98E-01 GSE3790 Homo sapiens Huntington's disease CNS, brain, cerebellum (MMHCC) 259 1.31 1.87E-01 3.03E-01 GSE2503 Homo sapiens Actinic keratos lymphocyte 271 1.16 2.45E-01 3.73E-01 GSE474 Homo sapiens Obesity Muscle, striated (skeletal) (MMHCC) 272 1.14 2.50E-01 3.78E-01 EXPE-MEXP-669 NULL Neuroblastoma Adrenal cortex 273 1.12 2.62E-01 3.95E-01 GSE3889 Mus musculus Hypercholesterolemia Hepatic tissue 274 1.11 2.66E-01 3.97 adenocarcinoma of lung Lung tissue 285 1 3.18E-01 4.58E-01 GSE4333 Mus musculus Lymphatic edema Skin tissue 286 0.99 3.22E-01 4.62E-01 GSE10964 Mus musculus COPD Lung 287 0.99 3.28E-01 4.69E-01 GSE2657 Homo sapiens Sarcoidosis T lymphocyte 288 0.96 3.41E-01 4.81E-01 GSE1767 Hom 303 0.8 4.28E-01 5.70E-01 GSE3195 Mus musculus hypoxia Fibroblast 304 0.79 4.28E-01 5.70E-01 GSE475 Homo sapiens COPD Muscle, striated (skeletal), diaphragm (MMHCC) 305 0.79 4.34E-01 5.75E-01 GSE1872 Rattus norvegicus Breast cancer Mammary gland tissue 306 0.79 4.29E-01 5.70E-01 GSE 6.42E-01 EXPE-MEXP-476 Homo sapiens Cancer of prostate Endothelial cell 315 0.66 5.10E-01 6.54E-01 GSE9877 Homo sapiens Sickle cell anemia Endothelial cell 316 0.65 5.18E-01 6.62E-01 GSE3026 Homo sapiens Bacterial infection Peripheral blood mononuclear cell 317 0.63 5.30E-01 6.76E-01 GSE128 Mus Muscle, striated (skeletal), diaphragm (MMHCC) 327 0.57 5.70E-01 7.02E-01 GSE2236 Mus musculus Congestive heart disease Myocardial tissue 328 0.56 5.74E-01 7.03E-01 GSE1008 Mus musculus DMD Extraocular muscle 329 0.53 5.90E-01 7.15E-01 GSE1472 Mus musculus APECED Thymic epithelial cell 331 0. deficiency Bone marrow stem cell 341 0.4 6.89E-01 7.90E-01 GSE3 Homo sapiens Clear cell carcinoma of kidney Renal cell 342 0.38 7.02E-01 7.97E-01 GSE9692 Homo sapiens Septic shock Whole blood 343 0.38 7.01E-01 8.01E-01 GSE6740 Homo sapiens HIV T lymphocyte 344 0.36 7.13E-01 8.03E-01 GSE121 Homo sapiens Type 2 diabetes IUGR Decidua basalis 356 0.15 8.82E-01 9.28E-01 GSE4697 Mus musculus Obesity Adipose tissue 357 0.12 9.02E-01 9.43E-01 GSE3249 Mus musculus Leber congenital amaurosis Retina 358 0.12 9.02E-01 9.43E-01 GSE1852 Mus musculus marfan\u2019s syndrome Myocardial tissue 359 0.08 9.34E-01 9. emia Blood monocyte 370 0.02 9.81E-01 9.89E-01 GSE10474 Homo sapiens Acute lung injury Whole blood 371 0.02 9.81E-01 9.89E-01 GSE574 Homo sapiens Purpura, idiopathic thrombocytopenic T lymphocyte 372 0.02 9.80E-01 9.89E-01 GSE3827 Homo sapiens CBCL Skin tissue 373 0.03 9.76E-01 9.89E-01 GSE8835 chronic Blood neutrophil 383 0.19 8.42E-01 9.06E-01 GSE2171 Homo sapiens HIV infection Peripheral blood mononuclear cell 384 0.2 8.46E-01 9.08E-01 GSE4036 Homo sapiens Schizophrenia CNS, brain, cerebellum (MMHCC) 385 0.22 8.27E-01 8.93E-01 GSE14245 Homo sapiens Malignant tumor of pancreas Saliva 386 0.24 8. 0.4 6.96E-01 7.93E-01 GSE1719 Homo sapiens Macular degeneration Fibroblast 397 0.4 6.91E-01 7.90E-01 GSE2737 Homo sapiens Psoriasis vulgaris Epidermis 398 0.41 6.78E-01 7.81E-01 GSE2729 Homo sapiens Rotavirus infection of children Peripheral blood mononuclear cell 399 0.41 6.78E-01 7.81E-01 GSE14577 GSE2378 Homo sapiens Glaucoma Astrocyte 410 0.61 5.43E-01 6.86E-01 GSE11969 Homo sapiens Large cell carcinoma of lung Lung tissue 411 0.63 5.34E-01 6.77E-01 GSE1907 Homo sapiens Sarcoidosis Blood corpuscle 412 0.7 4.74E-01 6.17E-01 GSE3100 Mus musculus Cystic fibrosis Lung 413 0.74 4.62E-01 culus Huntington's disease CNS, brain, striatum (MMHCC) 423 1.23 2.19E-01 3.42E-01 GSE3284 Homo sapiens Bacterial infection Leukocyte 424 1.28 2.01E-01 3.18E-01 GSE3512 Rattus norvegicus Hyperlipidemia Hepatic tissue 425 1.29 1.97E-01 3.16E-01 EXPE-MEXP-357 Rattus norvegicus Hypertension Left we matched the juvenile plasticity signature to 436 disease signatures derived from public microarray data. high scores indicate that plasticity genes are significantly dysregulated by the disease. low scores indicate that the disease has no impact on plasticity genes. inflammation induced by LPS suppresses experience-dependent plasticity in juvenile cortex. inflammation induced by LPS suppresses experience-dependent plasticity in juvenile cortex. animal-level quantification of ocular dominance plasticity by CBI reflects extent of the ocular dominance shift after 3 d of MD. CBI was strongly increased in the LPS-treated group compared with saline-treated group (gray discs: CBI = 0.64 0.02, 7 mice) qPCR data are reported as the mean SEM. in contrast, LPS significantly suppressed the shift in cortical responsivity from the deprived contralateral eye to the nondeprived ipsilateral eye. this was quantified by an increase in CBI and an elimination of the right shift in the distribution of ODSs of single neurons. the study demonstrates the utility of this approach for identifying diseases that may disrupt plasticity. molecular matches indicate that plasticity and the disease phenotype share underlying molecular machinery. however, a given disease state may or may not have an impact on functional plasticity or related gene expression if the disease state is sufficiently localized and segregated from neural tissue. a common theme among these dysregulations is inflammation, a biological process that is well suited to communicate peripheral signals to the brain, disrupting plasticity. microglial activator Lcn2 is a member of both the juvenile and Lynx1/ plasticity signatures. Activation may inhibit microglia from carrying out their \u201cresting-state\u201d role in mediating experience-dependent plasticity. our work suggests a conflict between developmental cortical plasticity and immune-related molecular networks during inflammation. the baseline cortical expression signature at this early time point would be critical to gate global ocular dominance plasticity. peak acute inflammatory response, as measured by an increase in IL-1 in brain after peripheral LPS injection, is between 1 and 4 h. more work is needed to understand the molecular events underlying the functional changes seen within hours of MD. a single early life inflammatory insult increases susceptibility to seizure even into adulthood. chronic overexpression of inflammation-related genes in rodents causes increased or decreased susceptibility to seizure. epilepsy and inflammation may have immediate and long-term effects on epilepsy-related plasticity mechanisms. chronic and acute inflammation go hand in hand with disrupted plasticity. inflammation suppresses developmental cortical plasticity across a wide variety of neurological and neurodevelopmental conditions. this suggests a potential public health concern related to neurodevelopmental trajectory. inflammation disrupts developmental cortical plasticity. it is likely that inflammation could disrupt plasticity in other systems. a bioinformatics approach is well suited to interrogate interactions between disease processes and disruptions in developmental plasticity. the approach is not limited to interrogating neurodevelopment but can be extended to other neurological signatures beyond plasticity. the approach is original and the results would be interesting, however there are many parts especially concerning Fig 2-4 that are not clearly described. 8 of 13 genes predicted to be anti-correlated to the plasticity signature showed a complete reversal in their differential expression pattern after LPS administration. it is unclear where is this prediction coming from. a cortical lesion impairs OD plasticity. the authors used an experimental approach (LPS exposure) to verify their hypothesis concluded from the first step by artificially inducing an inflammatory response in mice. the authors cite and propose that the study showed, that this is a valid approach. a nice experimental set to strengthen the hypothesis that inflammation is sufficient to suppress plasticity in the model used. it would be interesting to know why the tissue samples were taken 4 hours after LPS injection and the in vivo measurements were done 3 days after LPS injection."}